- Home
- MDWD vs GMGI Comparison
MDWD vs GMGI Comparison
Compare MDWD & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDWD
- GMGI
- Stock Information
- Founded
- MDWD 2000
- GMGI 2008
- Country
- MDWD Israel
- GMGI United States
- Employees
- MDWD N/A
- GMGI N/A
- Industry
- MDWD Medicinal Chemicals and Botanical Products
- GMGI Computer Software: Prepackaged Software
- Sector
- MDWD Health Care
- GMGI Technology
- Exchange
- MDWD Nasdaq
- GMGI Nasdaq
- Market Cap
- MDWD 208.2M
- GMGI 220.8M
- IPO Year
- MDWD 2014
- GMGI N/A
- Fundamental
- Price
- MDWD $18.63
- GMGI $1.40
- Analyst Decision
- MDWD Strong Buy
- GMGI Strong Buy
- Analyst Count
- MDWD 2
- GMGI 1
- Target Price
- MDWD $35.00
- GMGI $4.00
- AVG Volume (30 Days)
- MDWD 66.7K
- GMGI 178.2K
- Earning Date
- MDWD 08-14-2025
- GMGI 08-06-2025
- Dividend Yield
- MDWD N/A
- GMGI N/A
- EPS Growth
- MDWD N/A
- GMGI N/A
- EPS
- MDWD N/A
- GMGI N/A
- Revenue
- MDWD $19,213,000.00
- GMGI $172,818,124.00
- Revenue This Year
- MDWD $20.64
- GMGI $28.44
- Revenue Next Year
- MDWD $25.71
- GMGI $18.24
- P/E Ratio
- MDWD N/A
- GMGI N/A
- Revenue Growth
- MDWD N/A
- GMGI 54.66
- 52 Week Low
- MDWD $14.14
- GMGI $1.33
- 52 Week High
- MDWD $22.51
- GMGI $3.06
- Technical
- Relative Strength Index (RSI)
- MDWD 41.12
- GMGI 33.28
- Support Level
- MDWD $17.60
- GMGI $1.45
- Resistance Level
- MDWD $19.12
- GMGI $1.62
- Average True Range (ATR)
- MDWD 0.79
- GMGI 0.11
- MACD
- MDWD -0.15
- GMGI -0.02
- Stochastic Oscillator
- MDWD 37.84
- GMGI 10.53
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.